Q4 2023 Pharmaxis Ltd Activities Report Call Transcript
Good afternoon, everyone. Our clock has now ticked pass midday. So we'll get started with today's quarterly investor briefing with Pharmaxis CEO, Gary Phillips, who also has some updates from the FDA. My name is Alfred, I'm part of Pharmaxis Investor Relations team, I will assist in running call. (Operator Instructions)
It's obviously a very busy day on the AXS explained the last day of month. And there's plenty of information for investors to dissect, including these new FDA developments with Pharmaxis. So Gary, I won't take up anymore of your time. Let me hand over to you.
Thanks, Alfred, and good afternoon, everybody. I presented a couple of investor meetings in the last few weeks and today is a good chance to pull some of the threads that have been going on together and draw some conclusions about where we are as a company right now. Because obviously, we released lot of data in the last couple of months. I'm just going to go through the highlights of what we've announced. And then as Alfred say, I'm very happy to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
